Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 3
1948 3
1949 2
1951 34
1952 79
1953 86
1954 97
1955 106
1956 103
1957 82
1958 76
1959 86
1960 73
1961 93
1962 113
1963 220
1964 268
1965 155
1966 196
1967 238
1968 276
1969 262
1970 280
1971 313
1972 338
1973 293
1974 334
1975 276
1976 210
1977 229
1978 217
1979 167
1980 154
1981 118
1982 137
1983 151
1984 138
1985 159
1986 131
1987 155
1988 161
1989 165
1990 208
1991 277
1992 284
1993 264
1994 252
1995 278
1996 295
1997 308
1998 336
1999 291
2000 396
2001 378
2002 485
2003 526
2004 530
2005 637
2006 709
2007 774
2008 790
2009 863
2010 989
2011 1059
2012 1209
2013 1285
2014 1408
2015 1479
2016 1536
2017 1504
2018 1516
2019 1708
2020 1898
2021 2175
2022 2115
2023 2083
2024 2045
2025 2253
2026 1631

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39,631 results

Results by year

Filters applied: . Clear all
Page 1
Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment - A systematic review.
Tavares A, Moreira I. Tavares A, et al. Crit Rev Oncol Hematol. 2021 Apr;160:103294. doi: 10.1016/j.critrevonc.2021.103294. Epub 2021 Mar 3. Crit Rev Oncol Hematol. 2021. PMID: 33675907
INTRODUCTION: Diffuse large B cell Lymphoma (DLBCL) is a potentially curative lymphoma with increasing incidence with ageing. ...
INTRODUCTION: Diffuse large B cell Lymphoma (DLBCL) is a potentially curative lymphoma with increa …
Diffuse large-cell lymphoma.
Fisher RI. Fisher RI. Ann Oncol. 2000;11 Suppl 1:29-33. Ann Oncol. 2000. PMID: 10707775 Review.
BACKGROUND: New treatments are desperately needed to improve the results obtained using CHOP chemotherapy for patients with diffuse large cell lymphoma. In order to develop successful new strategies we need to understand why prior promising therapies h …
BACKGROUND: New treatments are desperately needed to improve the results obtained using CHOP chemotherapy for patients with diffuse …
Diffuse large cell lymphoma.
Coiffier B. Coiffier B. Curr Opin Oncol. 2001 Sep;13(5):325-34. doi: 10.1097/00001622-200109000-00003. Curr Opin Oncol. 2001. PMID: 11555708 Review.
A review of new or emerging ideas concerning diffuse large B-cell lymphomas is presented, with particular emphasis on histologic classification, genetic prognostic factors, first-line and salvage treatments, and specific locations such as neurologic, c …
A review of new or emerging ideas concerning diffuse large B-cell lymphomas is presented, with particular emphas …
Red Cell Distribution Width in Diffuse Large B-cell Lymphoma.
Daungsupawong H, Wiwanitkit V. Daungsupawong H, et al. Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3637. doi: 10.31557/APJCP.2023.24.11.3637. Asian Pac J Cancer Prev. 2023. PMID: 38019219 Free PMC article. No abstract available.
Antibodies for the treatment of diffuse large cell lymphoma.
Blum KA, Bartlett NL. Blum KA, et al. Semin Oncol. 2003 Aug;30(4):448-56. doi: 10.1016/s0093-7754(03)00251-3. Semin Oncol. 2003. PMID: 12939713 Review.
Perhaps the greatest change has occurred in first-line therapy of advanced stage, diffuse large cell lymphoma (DLCL), where rituximab combined with conventional chemotherapy has improved both overall survival (OS) and progression-free survival (PFS) ov …
Perhaps the greatest change has occurred in first-line therapy of advanced stage, diffuse large cell lymphoma (D …
Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma.
Farooq U, Laport GG. Farooq U, et al. Leuk Lymphoma. 2015 Jul;56(7):1930-7. doi: 10.3109/10428194.2014.975803. Epub 2014 Nov 20. Leuk Lymphoma. 2015. PMID: 25315072 Review.
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma histology, with 40% of patients cured with frontline therapy. Salvage chemotherapy followed by autologous hematopoietic cell transplant (HCT) remains the …
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma histology, with 40% …
Primary Diffuse Large B-Cell Lymphoma of the Frontal Sinus.
Kamboj A, Hwang CJ, Mokhtarzadeh A, Harrison AR. Kamboj A, et al. Ophthalmic Plast Reconstr Surg. 2023 Mar-Apr 01;39(2):e68. doi: 10.1097/IOP.0000000000002223. Epub 2022 Jun 3. Ophthalmic Plast Reconstr Surg. 2023. PMID: 35657643 No abstract available.
Primary diffuse large cell lymphoma of the mandible.
Rosado MF, Morgensztern D, Peleg M, Lossos IS. Rosado MF, et al. Leuk Lymphoma. 2004 May;45(5):1049-53. doi: 10.1080/10428190310001625737. Leuk Lymphoma. 2004. PMID: 15291366 Review.
Primary diffuse large cell lymphoma of the mandible is a rare form of extranodal non-Hodgkin's lymphoma (NHL). ...Multi-center prospective clinical trials are needed to determine the optimal therapeutic approach to this rare diffuse la …
Primary diffuse large cell lymphoma of the mandible is a rare form of extranodal non-Hodgkin's lymphoma ( …
39,631 results
You have reached the last available page of results. Please see the User Guide for more information.